MX2007002875A - Hexadecasacaridos biotinilados, su preparacion y su utilizacion. - Google Patents

Hexadecasacaridos biotinilados, su preparacion y su utilizacion.

Info

Publication number
MX2007002875A
MX2007002875A MX2007002875A MX2007002875A MX2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A
Authority
MX
Mexico
Prior art keywords
preparation
oso3
c6alkoxy
biotinylated hexadecasaccharides
hexadecasaccharides
Prior art date
Application number
MX2007002875A
Other languages
English (en)
Spanish (es)
Inventor
Maurice Petitou
Philippe Duchaussoy
Jean-Pascal Herault
Jean Marc Herbert
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007002875(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2007002875A publication Critical patent/MX2007002875A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
MX2007002875A 2004-09-09 2005-09-07 Hexadecasacaridos biotinilados, su preparacion y su utilizacion. MX2007002875A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
PCT/FR2005/002218 WO2006030104A1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation

Publications (1)

Publication Number Publication Date
MX2007002875A true MX2007002875A (es) 2007-05-16

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002875A MX2007002875A (es) 2004-09-09 2005-09-07 Hexadecasacaridos biotinilados, su preparacion y su utilizacion.

Country Status (38)

Country Link
US (3) US20070270342A1 (cg-RX-API-DMAC7.html)
EP (1) EP1791872B1 (cg-RX-API-DMAC7.html)
JP (1) JP5108519B2 (cg-RX-API-DMAC7.html)
KR (1) KR101223364B1 (cg-RX-API-DMAC7.html)
CN (1) CN101039963B (cg-RX-API-DMAC7.html)
AR (1) AR051286A1 (cg-RX-API-DMAC7.html)
AT (1) ATE420118T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005284080B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515078A (cg-RX-API-DMAC7.html)
CA (1) CA2577258C (cg-RX-API-DMAC7.html)
CY (1) CY1109126T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005012287D1 (cg-RX-API-DMAC7.html)
DK (1) DK1791872T3 (cg-RX-API-DMAC7.html)
EA (1) EA012587B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP077272A (cg-RX-API-DMAC7.html)
ES (1) ES2320576T3 (cg-RX-API-DMAC7.html)
FR (1) FR2874924B1 (cg-RX-API-DMAC7.html)
GT (1) GT200500250A (cg-RX-API-DMAC7.html)
HN (1) HN2005000518A (cg-RX-API-DMAC7.html)
HR (1) HRP20090180T1 (cg-RX-API-DMAC7.html)
IL (1) IL181569A (cg-RX-API-DMAC7.html)
MA (1) MA28859B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007002875A (cg-RX-API-DMAC7.html)
MY (1) MY140666A (cg-RX-API-DMAC7.html)
NI (1) NI200700063A (cg-RX-API-DMAC7.html)
NO (1) NO20071754L (cg-RX-API-DMAC7.html)
PA (1) PA8644201A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060663A1 (cg-RX-API-DMAC7.html)
PL (1) PL1791872T3 (cg-RX-API-DMAC7.html)
PT (1) PT1791872E (cg-RX-API-DMAC7.html)
RS (1) RS50762B (cg-RX-API-DMAC7.html)
SI (1) SI1791872T1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002221A (cg-RX-API-DMAC7.html)
TN (1) TNSN07053A1 (cg-RX-API-DMAC7.html)
TW (1) TW200612970A (cg-RX-API-DMAC7.html)
UY (1) UY29102A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006030104A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200702255B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
MA28859B1 (fr) 2007-09-03
SI1791872T1 (sl) 2009-06-30
EA200700594A1 (ru) 2007-08-31
PT1791872E (pt) 2009-03-27
NI200700063A (es) 2008-03-07
EP1791872A1 (fr) 2007-06-06
CA2577258A1 (fr) 2006-03-23
DK1791872T3 (da) 2009-05-04
CY1109126T1 (el) 2014-07-02
AU2005284080A1 (en) 2006-03-23
EP1791872B1 (fr) 2009-01-07
MY140666A (en) 2010-01-15
ECSP077272A (es) 2007-03-29
TW200612970A (en) 2006-05-01
AU2005284080B2 (en) 2011-10-13
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
US20100279960A1 (en) 2010-11-04
NO20071754L (no) 2007-04-02
HN2005000518A (es) 2009-06-01
SV2006002221A (es) 2006-01-13
PE20060663A1 (es) 2006-08-21
BRPI0515078A (pt) 2008-07-01
PA8644201A1 (es) 2006-05-16
US8557968B2 (en) 2013-10-15
HRP20090180T1 (en) 2009-05-31
ES2320576T3 (es) 2009-05-25
KR101223364B1 (ko) 2013-01-16
US20130004551A1 (en) 2013-01-03
AR051286A1 (es) 2007-01-03
US8703738B2 (en) 2014-04-22
FR2874924B1 (fr) 2006-12-01
TNSN07053A1 (fr) 2008-06-02
RS50762B (sr) 2010-08-31
ZA200702255B (en) 2008-09-25
CN101039963B (zh) 2011-07-27
HK1113686A1 (en) 2008-10-10
GT200500250A (es) 2006-04-10
US20070270342A1 (en) 2007-11-22
IL181569A0 (en) 2007-07-04
JP2008512538A (ja) 2008-04-24
EA012587B1 (ru) 2009-10-30
KR20070051887A (ko) 2007-05-18
CN101039963A (zh) 2007-09-19
CA2577258C (fr) 2013-05-21
UY29102A1 (es) 2006-04-28
ATE420118T1 (de) 2009-01-15
WO2006030104A1 (fr) 2006-03-23
IL181569A (en) 2011-08-31
PL1791872T3 (pl) 2009-06-30
JP5108519B2 (ja) 2012-12-26

Similar Documents

Publication Publication Date Title
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
MY147211A (en) Novel dihydropseudoerythromycin derivatives
DE602004008895D1 (en) Dpp-iv-hemmer
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
TW200628161A (en) Novel betulin derivatives, preparation thereof and use thereof
ATE493386T1 (de) Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate
WO2006048330A8 (en) 11βετα-hsd1 inhibitors
WO2009057079A3 (en) Novel pyrimidine derivatives
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
WO2007084728A3 (en) 2-imino-benzimidazoles
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
NO20070089L (no) DPP-IV inhibitorer
WO2006072458A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
MXPA05013758A (es) Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas.
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
WO2007012626A3 (de) Neues verfahren zur herstellung von tiotropiumsalzen
IL195897A0 (en) Novel 4-amino-3-(-azolyl-phenoxymethyl)-thieno[3,2]pyridine-7-carboxylic acid derivatives
MY140666A (en) Biotinylated hexadecasaccharides, preparation and use thereof

Legal Events

Date Code Title Description
FG Grant or registration